Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure.
AUTOR(ES)
Murphy, J J
RESUMO
Ten patients with chronic heart failure were given a continuous infusion of dopexamine after an initial stage of dose titration. On the dose selected the cardiac index initially rose by 56%, as a result of an increase in both heart rate and stroke volume index. Systemic vascular resistance fell by 34% and the mean arterial pressure did not change. Within 18 hours of the start of the continuous infusion, however, all the variables except heart rate had returned to preinfusion values. Nine of the 10 patients were withdrawn from the 48 hour study, six because of haemodynamic deterioration and two because of side effects. If the premature loss of therapeutic effect reflects an intrinsic property of this agent, dopexamine may be of limited clinical value.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1216513Documentos Relacionados
- Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.
- Haemodynamic effects of pregnancy in patients with heart failure.
- Haemodynamic effects of hydralazine at rest and during exercise in patients with chronic heart failure.
- Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
- Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure.